{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:10:25Z","timestamp":1790971825358,"version":"4.1.0"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009863","name":"Neuroendocrine Tumor Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009863","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11102-022-01211-5","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T12:30:59Z","timestamp":1645533059000},"page":"363-382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4959-5725","authenticated-orcid":false,"given":"Pedro","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Lu\u00edsa","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"L\u00f3pez-Presa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jo\u00e3o","family":"Bugalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"issue":"3","key":"1211_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-013-1354-5","volume":"117","author":"ED Aflorei","year":"2014","unstructured":"Aflorei ED, Korbonits M (2014) Epidemiology and etiopathogenesis of pituitary adenomas. J Neurooncol 117(3):379\u2013394. https:\/\/doi.org\/10.1007\/s11060-013-1354-5","journal-title":"J Neurooncol"},{"issue":"10","key":"1211_CR2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"Melmed S (2020) Pituitary-tumor endocrinopathies. N Engl J Med 382(10):937\u2013950. https:\/\/doi.org\/10.1056\/NEJMra1810772","journal-title":"N Engl J Med"},{"issue":"2","key":"1211_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ecl.2017.01.004","volume":"46","author":"P Marques","year":"2017","unstructured":"Marques P, Korbonits M (2017) Genetic aspects of pituitary adenomas. Endocrinol Metab Clin North Am 46(2):335\u2013374. https:\/\/doi.org\/10.1016\/j.ecl.2017.01.004","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"7","key":"1211_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrendo.2014.64","volume":"10","author":"A Di Ieva","year":"2014","unstructured":"Di Ieva A, Rotondo F, Syro LV, Cusimano MD, Kovacs K (2014) Aggressive pituitary adenomas\u2013diagnosis and emerging treatments. Nat Rev Endocrinol 10(7):423\u2013435. https:\/\/doi.org\/10.1038\/nrendo.2014.64","journal-title":"Nat Rev Endocrinol"},{"key":"1211_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-019-09531-x","author":"L Kasuki","year":"2019","unstructured":"Kasuki L, Raverot G (2019) Definition and diagnosis of aggressive pituitary tumors. Rev Endocr Metab Disord. https:\/\/doi.org\/10.1007\/s11154-019-09531-x","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"1211_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/cancers12020514","volume":"12","author":"J Trouillas","year":"2020","unstructured":"Trouillas J, Jaffrain-Rea ML, Vasiljevic A, Raverot G, Roncaroli F, Villa C (2020) How to classify the pituitary neuroendocrine tumors (PitNET)s in 2020. Cancers (Basel) 12(2):10. https:\/\/doi.org\/10.3390\/cancers12020514","journal-title":"Cancers (Basel)"},{"key":"1211_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000345673","volume":"41","author":"MR Gadelha","year":"2013","unstructured":"Gadelha MR, Trivellin G, Hernandez Ramirez LC, Korbonits M (2013) Genetics of pituitary adenomas. Front Horm Res 41:111\u2013140. https:\/\/doi.org\/10.1159\/000345673","journal-title":"Front Horm Res"},{"issue":"3","key":"1211_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ecl.2020.05.005","volume":"49","author":"S Barry","year":"2020","unstructured":"Barry S, Korbonits M (2020) Update on the genetics of pituitary tumors. Endocrinol Metab Clin North Am 49(3):433\u2013452. https:\/\/doi.org\/10.1016\/j.ecl.2020.05.005","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"1211_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrendo.2011.40","volume":"7","author":"S Melmed","year":"2011","unstructured":"Melmed S (2011) Pathogenesis of pituitary tumors. Nat Rev Endocrinol 7(5):257\u2013266. https:\/\/doi.org\/10.1038\/nrendo.2011.40","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"1211_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2014.11.004","volume":"44","author":"S Melmed","year":"2015","unstructured":"Melmed S (2015) Pituitary tumors. Endocrinol Metab Clin North Am 44(1):1\u20139. https:\/\/doi.org\/10.1016\/j.ecl.2014.11.004","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"1211_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","volume":"47","author":"M Reincke","year":"2015","unstructured":"Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F et al (2015) Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nat Genet 47(1):31\u201338. https:\/\/doi.org\/10.1038\/ng.3166","journal-title":"Nat Genet"},{"key":"1211_CR12","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa006","author":"V Srirangam Nadhamuni","year":"2020","unstructured":"Srirangam Nadhamuni V, Korbonits M (2020) Novel insights into pituitary tumorigenesis: genetic and epigenetic mechanisms. Endocr Rev. https:\/\/doi.org\/10.1210\/endrev\/bnaa006","journal-title":"Endocr Rev"},{"key":"1211_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101605","author":"MD Ilie","year":"2019","unstructured":"Ilie MD, Vasiljevic A, Raverot G, Bertolino P (2019) The microenvironment of pituitary tumors-biological and therapeutic implications. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11101605","journal-title":"Cancers (Basel)"},{"key":"1211_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2020.100852","volume":"58","author":"P Marques","year":"2020","unstructured":"Marques P, Grossman AB, Korbonits M (2020) The tumour microenvironment of pituitary neuroendocrine tumours. Front Neuroendocrinol 58:100852. https:\/\/doi.org\/10.1016\/j.yfrne.2020.100852","journal-title":"Front Neuroendocrinol"},{"issue":"3","key":"1211_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/path.4298","volume":"232","author":"LE Drake","year":"2014","unstructured":"Drake LE, Macleod KF (2014) Tumour suppressor gene function in carcinoma-associated fibroblasts: from tumour cells via EMT and back again? J Pathol 232(3):283\u2013288. https:\/\/doi.org\/10.1002\/path.4298","journal-title":"J Pathol"},{"issue":"2","key":"1211_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/path.3029","volume":"226","author":"FR Balkwill","year":"2012","unstructured":"Balkwill FR (2012) The chemokine system and cancer. J Pathol 226(2):148\u2013157. https:\/\/doi.org\/10.1002\/path.3029","journal-title":"J Pathol"},{"issue":"Pt 23","key":"1211_CR17","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","volume":"125","author":"FR Balkwill","year":"2012","unstructured":"Balkwill FR, Capasso M, Hagemann T (2012) The tumor microenvironment at a glance. J Cell Sci 125(Pt 23):5591\u20135596. https:\/\/doi.org\/10.1242\/jcs.116392","journal-title":"J Cell Sci"},{"key":"1211_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102870","author":"I Falcone","year":"2020","unstructured":"Falcone I, Conciatori F, Bazzichetto C, Ferretti G, Cognetti F, Ciuffreda L et al (2020) Tumor microenvironment: implications in melanoma resistance to targeted therapy and immunotherapy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12102870","journal-title":"Cancers (Basel)."},{"key":"1211_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164233","author":"JJ Li","year":"2021","unstructured":"Li JJ, Tsang JY, Tse GM (2021) Tumor microenvironment in breast cancer-updates on therapeutic implications and pathologic assessment. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13164233","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1211_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ags3.12225","volume":"3","author":"T Murakami","year":"2019","unstructured":"Murakami T, Hiroshima Y, Matsuyama R, Homma Y, Hoffman RM, Endo I (2019) Role of the tumor microenvironment in pancreatic cancer. Ann Gastroenterol Surg 3(2):130\u2013137. https:\/\/doi.org\/10.1002\/ags3.12225","journal-title":"Ann Gastroenterol Surg"},{"issue":"1","key":"1211_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s40478-019-0830-3","volume":"7","author":"P Marques","year":"2019","unstructured":"Marques P, Barry S, Carlsen E, Collier D, Ronaldson A, Awad S et al (2019) Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours. Acta Neuropathol Commun 7(1):172. https:\/\/doi.org\/10.1186\/s40478-019-0830-3","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"1211_CR22","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1530\/ERC-19-0327","volume":"26","author":"P Marques","year":"2019","unstructured":"Marques P, Barry S, Carlsen E, Collier D, Ronaldson A, Awad S et al (2019) Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness. Endocr Relat Cancer 26(12):853\u2013865. https:\/\/doi.org\/10.1530\/ERC-19-0327","journal-title":"Endocr Relat Cancer"},{"key":"1211_CR23","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa520","author":"M Principe","year":"2020","unstructured":"Principe M, Chanal M, Ilie MD, Ziverec A, Vasiljevic A, Jouanneau E et al (2020) Immune landscape of pituitary tumors reveals association between macrophages and gonadotroph tumor invasion. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa520","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1211_CR24","doi-asserted-by":"publisher","first-page":"T283","DOI":"10.1530\/ERC-17-0146","volume":"24","author":"S Gasser","year":"2017","unstructured":"Gasser S, Lim LHK, Cheung FSG (2017) The role of the tumour microenvironment in immunotherapy. Endocr Relat Cancer 24(12):T283\u2013T295. https:\/\/doi.org\/10.1530\/ERC-17-0146","journal-title":"Endocr Relat Cancer"},{"key":"1211_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.608422","volume":"11","author":"C Dai","year":"2020","unstructured":"Dai C, Liang S, Sun B, Kang J (2020) The progress of immunotherapy in refractory pituitary adenomas and pituitary carcinomas. Front Endocrinol (Lausanne) 11:608422. https:\/\/doi.org\/10.3389\/fendo.2020.608422","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1211_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semcancer.2011.12.005","volume":"22","author":"FR Balkwill","year":"2012","unstructured":"Balkwill FR, Mantovani A (2012) Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol 22(1):33\u201340. https:\/\/doi.org\/10.1016\/j.semcancer.2011.12.005","journal-title":"Semin Cancer Biol"},{"issue":"7203","key":"1211_CR27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436\u2013444. https:\/\/doi.org\/10.1038\/nature07205","journal-title":"Nature"},{"key":"1211_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02145-y","author":"D Iacovazzo","year":"2019","unstructured":"Iacovazzo D, Chiloiro S, Carlsen E, Bianchi A, Giampietro A, Tartaglione T et al (2019) Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours. Endocrine. https:\/\/doi.org\/10.1007\/s12020-019-02145-y","journal-title":"Endocrine"},{"issue":"3","key":"1211_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12022-015-9383-6","volume":"26","author":"JQ Lu","year":"2015","unstructured":"Lu JQ, Adam B, Jack AS, Lam A, Broad RW, Chik CL (2015) Immune cell infiltrates in pituitary adenomas: more macrophages in larger adenomas and more T cells in growth hormone adenomas. Endocr Pathol 26(3):263\u2013272. https:\/\/doi.org\/10.1007\/s12022-015-9383-6","journal-title":"Endocr Pathol"},{"issue":"8","key":"1211_CR30","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.7150\/thno.53749","volume":"11","author":"A Zhang","year":"2021","unstructured":"Zhang A, Xu Y, Xu H, Ren J, Meng T, Ni Y et al (2021) Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17. Theranostics 11(8):3839\u20133852. https:\/\/doi.org\/10.7150\/thno.53749","journal-title":"Theranostics"},{"key":"1211_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03476-x","author":"JT Yeung","year":"2020","unstructured":"Yeung JT, Vesely MD, Miyagishima DF (2020) In silico analysis of the immunological landscape of pituitary adenomas. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-020-03476-x","journal-title":"J Neurooncol"},{"issue":"3","key":"1211_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11060-020-03636-z","volume":"149","author":"W Zhou","year":"2020","unstructured":"Zhou W, Zhang C, Zhang D, Peng J, Ma S, Wang X et al (2020) Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomas. J Neurooncol 149(3):473\u2013487. https:\/\/doi.org\/10.1007\/s11060-020-03636-z","journal-title":"J Neurooncol"},{"key":"1211_CR33","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa449","author":"Z Wang","year":"2020","unstructured":"Wang Z, Guo X, Gao L, Deng K, Lian W, Bao X et al (2020) The immune profile of pituitary adenomas and a novel immune classification for predicting immunotherapy responsiveness. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa449","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1211_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1210\/jc.2009-1583","volume":"95","author":"I Lupi","year":"2010","unstructured":"Lupi I, Manetti L, Caturegli P, Menicagli M, Cosottini M, Iannelli A et al (2010) Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma. J Clin Endocrinol Metab 95(1):289\u2013296. https:\/\/doi.org\/10.1210\/jc.2009-1583","journal-title":"J Clin Endocrinol Metab"},{"issue":"27","key":"1211_CR35","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1038\/s41388-019-0779-5","volume":"38","author":"S Barry","year":"2019","unstructured":"Barry S, Carlsen E, Marques P, Stiles CE, Gadaleta E, Berney DM et al (2019) Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors. Oncogene 38(27):5381\u20135395. https:\/\/doi.org\/10.1038\/s41388-019-0779-5","journal-title":"Oncogene"},{"issue":"1","key":"1211_CR36","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12957-021-02272-9","volume":"19","author":"D Nie","year":"2021","unstructured":"Nie D, Fang Q, Li B, Cheng J, Li C, Gui S et al (2021) Research advances on the immune research and prospect of immunotherapy in pituitary adenomas. World J Surg Oncol 19(1):162. https:\/\/doi.org\/10.1186\/s12957-021-02272-9","journal-title":"World J Surg Oncol"},{"issue":"3","key":"1211_CR37","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11102-020-01114-3","volume":"24","author":"Y Mei","year":"2021","unstructured":"Mei Y, Bi WL, Agolia J, Hu C, Giantini Larsen AM, Meredith DM et al (2021) Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression. Pituitary 24(3):359\u2013373. https:\/\/doi.org\/10.1007\/s11102-020-01114-3","journal-title":"Pituitary"},{"issue":"6","key":"1211_CR38","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1177\/030089169007600605","volume":"76","author":"ML Rossi","year":"1990","unstructured":"Rossi ML, Jones NR, Esiri MM, Havas L, Al Izzi M, Coakham HB (1990) Mononuclear cell infiltrate and HLA-Dr expression in 28 pituitary adenomas. Tumori 76(6):543\u2013547","journal-title":"Tumori"},{"issue":"3","key":"1211_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1507\/endocrj.45.357","volume":"45","author":"HM Heshmati","year":"1998","unstructured":"Heshmati HM, Kujas M, Casanova S, Wollan PC, Racadot J, Van Effenterre R et al (1998) Prevalence of lymphocytic infiltrate in 1400 pituitary adenomas. Endocr J 45(3):357\u2013361","journal-title":"Endocr J"},{"issue":"4","key":"1211_CR40","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1215\/15228517-2008-104","volume":"11","author":"JF Jacobs","year":"2009","unstructured":"Jacobs JF, Idema AJ, Bol KF, Nierkens S, Grauer OM, Wesseling P et al (2009) Regulatory T cells and the PD-L1\/PD-1 pathway mediate immune suppression in malignant human brain tumors. Neuro Oncol 11(4):394\u2013402. https:\/\/doi.org\/10.1215\/15228517-2008-104","journal-title":"Neuro Oncol"},{"issue":"1","key":"1211_CR41","doi-asserted-by":"publisher","first-page":"19373","DOI":"10.1038\/s41598-020-76555-8","volume":"10","author":"K Taniguchi-Ponciano","year":"2020","unstructured":"Taniguchi-Ponciano K, Andonegui-Elguera S, Pena-Martinez E, Silva-Roman G, Vela-Patino S, Gomez-Apo E et al (2020) Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors. Sci Rep 10(1):19373. https:\/\/doi.org\/10.1038\/s41598-020-76555-8","journal-title":"Sci Rep"},{"issue":"13","key":"1211_CR42","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1073\/pnas.81.13.4174","volume":"81","author":"DA Hume","year":"1984","unstructured":"Hume DA, Halpin D, Charlton H, Gordon S (1984) The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4\/80: macrophages of endocrine organs. Proc Natl Acad Sci U S A 81(13):4174\u20134177","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1211_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s004410050704","volume":"286","author":"TH Mander","year":"1996","unstructured":"Mander TH, Morris JF (1996) Development of microglia and macrophages in the postnatal rat pituitary. Cell Tissue Res 286(3):347\u2013355","journal-title":"Cell Tissue Res"},{"issue":"2","key":"1211_CR44","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00441-016-2564-x","volume":"368","author":"K Fujiwara","year":"2017","unstructured":"Fujiwara K, Yatabe M, Tofrizal A, Jindatip D, Yashiro T, Nagai R (2017) Identification of M2 macrophages in anterior pituitary glands of normal rats and rats with estrogen-induced prolactinoma. Cell Tissue Res 368(2):371\u2013378. https:\/\/doi.org\/10.1007\/s00441-016-2564-x","journal-title":"Cell Tissue Res"},{"issue":"3","key":"1211_CR45","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10555-006-9001-7","volume":"25","author":"A Mantovani","year":"2006","unstructured":"Mantovani A, Schioppa T, Porta C, Allavena P, Sica A (2006) Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25(3):315\u2013322. https:\/\/doi.org\/10.1007\/s10555-006-9001-7","journal-title":"Cancer Metastasis Rev"},{"issue":"11","key":"1211_CR46","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549\u2013555","journal-title":"Trends Immunol"},{"issue":"47","key":"1211_CR47","doi-asserted-by":"publisher","first-page":"76565","DOI":"10.18632\/oncotarget.12088","volume":"7","author":"Y Mei","year":"2016","unstructured":"Mei Y, Bi WL, Greenwald NF, Du Z, Agar NY, Kaiser UB et al (2016) Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors. Oncotarget 7(47):76565\u201376576. https:\/\/doi.org\/10.18632\/oncotarget.12088","journal-title":"Oncotarget"},{"issue":"1","key":"1211_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11060-018-2844-2","volume":"139","author":"PF Wang","year":"2018","unstructured":"Wang PF, Wang TJ, Yang YK, Yao K, Li Z, Li YM et al (2018) The expression profile of PD-L1 and CD8(+) lymphocyte in pituitary adenomas indicating for immunotherapy. J Neurooncol 139(1):89\u201395. https:\/\/doi.org\/10.1007\/s11060-018-2844-2","journal-title":"J Neurooncol"},{"issue":"17","key":"1211_CR49","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1158\/1078-0432.CCR-17-2206","volume":"24","author":"MP Salomon","year":"2018","unstructured":"Salomon MP, Wang X, Marzese DM, Hsu SC, Nelson N, Zhang X et al (2018) The epigenomic landscape of pituitary adenomas reveals specific alterations and differentiates among acromegaly, cushing\u2019s disease and endocrine-inactive subtypes. Clin Cancer Res 24(17):4126\u20134136. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2206","journal-title":"Clin Cancer Res"},{"key":"1211_CR50","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3486","author":"HR Kemeny","year":"2019","unstructured":"Kemeny HR, Elsamadicy AA, Farber SH, Champion CD, Lorrey SJ, Chongsathidkiet P et al (2019) Targeting PD-L1 initiates effective anti-tumor immunity in a murine model of Cushing\u2019s Disease. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3486","journal-title":"Clin Cancer Res"},{"issue":"1\u20132","key":"1211_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10555-011-9340-x","volume":"31","author":"P Cirri","year":"2012","unstructured":"Cirri P, Chiarugi P (2012) Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev 31(1\u20132):195\u2013208. https:\/\/doi.org\/10.1007\/s10555-011-9340-x","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"1211_CR52","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.3390\/cancers7040902","volume":"7","author":"K Shiga","year":"2015","unstructured":"Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Takeyama H (2015) Cancer-associated fibroblasts: their characteristics and their roles in tumor growth. Cancers (Basel) 7(4):2443\u20132458. https:\/\/doi.org\/10.3390\/cancers7040902","journal-title":"Cancers (Basel)"},{"issue":"27","key":"1211_CR53","doi-asserted-by":"publisher","first-page":"41584","DOI":"10.18632\/oncotarget.9296","volume":"7","author":"S Moatassim-Billah","year":"2016","unstructured":"Moatassim-Billah S, Duluc C, Samain R, Jean C, Perraud A, Decaup E et al (2016) Anti-metastatic potential of somatostatin analog SOM230: indirect pharmacological targeting of pancreatic cancer-associated fibroblasts. Oncotarget 7(27):41584\u201341598. https:\/\/doi.org\/10.18632\/oncotarget.9296","journal-title":"Oncotarget"},{"issue":"5","key":"1211_CR54","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1089\/ten.TEC.2009.0596","volume":"16","author":"WL Chen","year":"2010","unstructured":"Chen WL, Huang CH, Chiou LL, Chen TH, Huang YY, Jiang CC et al (2010) Multiphoton imaging and quantitative analysis of collagen production by chondrogenic human mesenchymal stem cells cultured in chitosan scaffold. Tissue Eng Part C Methods 16(5):913\u2013920. https:\/\/doi.org\/10.1089\/ten.TEC.2009.0596","journal-title":"Tissue Eng Part C Methods"},{"issue":"Pt 1","key":"1211_CR55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1242\/jcs.115.1.39","volume":"115","author":"T Gudjonsson","year":"2002","unstructured":"Gudjonsson T, Ronnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW (2002) Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci 115(Pt 1):39\u201350","journal-title":"J Cell Sci"},{"issue":"2","key":"1211_CR56","first-page":"452","volume":"74","author":"C Sundberg","year":"1996","unstructured":"Sundberg C, Ivarsson M, Gerdin B, Rubin K (1996) Pericytes as collagen-producing cells in excessive dermal scarring. Lab Invest 74(2):452\u2013466","journal-title":"Lab Invest"},{"issue":"4","key":"1211_CR57","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s00795-016-0140-9","volume":"49","author":"A Tofrizal","year":"2016","unstructured":"Tofrizal A, Fujiwara K, Yashiro T, Yamada S (2016) Alterations of collagen-producing cells in human pituitary adenomas. Med Mol Morphol 49(4):224\u2013232. https:\/\/doi.org\/10.1007\/s00795-016-0140-9","journal-title":"Med Mol Morphol"},{"issue":"4","key":"1211_CR58","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1055\/s-0043-119636","volume":"126","author":"L Lv","year":"2018","unstructured":"Lv L, Zhang S, Hu Y, Zhou P, Gao L, Wang M et al (2018) Invasive pituitary adenoma-derived tumor-associated fibroblasts promote tumor progression both in vitro and in vivo. Exp Clin Endocrinol Diabetes 126(4):213\u2013221. https:\/\/doi.org\/10.1055\/s-0043-119636","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"1211_CR59","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1365-2826.2008.01716.x","volume":"20","author":"S Devnath","year":"2008","unstructured":"Devnath S, Inoue K (2008) An insight to pituitary folliculo-stellate cells. J Neuroendocrinol 20(6):687\u2013691. https:\/\/doi.org\/10.1111\/j.1365-2826.2008.01716.x","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"1211_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00003.2011","volume":"92","author":"C Perez-Castro","year":"2012","unstructured":"Perez-Castro C, Renner U, Haedo MR, Stalla GK, Arzt E (2012) Cellular and molecular specificity of pituitary gland physiology. Physiol Rev 92(1):1\u201338. https:\/\/doi.org\/10.1152\/physrev.00003.2011","journal-title":"Physiol Rev"},{"issue":"1","key":"1211_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/eje.1.01949","volume":"153","author":"W Allaerts","year":"2005","unstructured":"Allaerts W, Vankelecom H (2005) History and perspectives of pituitary folliculo-stellate cell research. Eur J Endocrinol 153(1):1\u201312. https:\/\/doi.org\/10.1530\/eje.1.01949","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1211_CR62","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/BF02890202","volume":"47","author":"L Lauriola","year":"1984","unstructured":"Lauriola L, Cocchia D, Sentinelli S, Maggiano N, Maira G, Michetti F (1984) Immunohistochemical detection of folliculo-stellate cells in human pituitary adenomas. Virchows Arch B Cell Pathol Incl Mol Pathol 47(3):189\u2013197","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"issue":"3","key":"1211_CR63","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/01913129109021886","volume":"15","author":"A Sbarbati","year":"1991","unstructured":"Sbarbati A, Fakhreddine A, Zancanaro C, Bontempini L, Cinti S (1991) Ultrastructural morphology of folliculo-stellate cells in human pituitary adenomas. Ultrastruct Pathol 15(3):241\u2013248","journal-title":"Ultrastruct Pathol"},{"issue":"5","key":"1211_CR64","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/BF00686384","volume":"76","author":"O Tachibana","year":"1988","unstructured":"Tachibana O, Yamashima T (1988) Immunohistochemical study of folliculo-stellate cells in human pituitary adenomas. Acta Neuropathol 76(5):458\u2013464","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1211_CR65","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0344-0338(99)80026-0","volume":"195","author":"D Voit","year":"1999","unstructured":"Voit D, Saeger W, Ludecke DK (1999) Folliculo-stellate cells in pituitary adenomas of patients with acromegaly. Pathol Res Pract 195(3):143\u2013147. https:\/\/doi.org\/10.1016\/S0344-0338(99)80026-0","journal-title":"Pathol Res Pract"},{"issue":"7","key":"1211_CR66","first-page":"297","volume":"63","author":"F Tortosa","year":"2016","unstructured":"Tortosa F, Pires M, Ortiz S (2016) Prognostic implications of folliculo-stellate cells in pituitary adenomas: relationship with tumoral behavior. Rev Neurol 63(7):297\u2013302","journal-title":"Rev Neurol"},{"issue":"6","key":"1211_CR67","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1055\/s-0029-1211777","volume":"105","author":"U Renner","year":"1997","unstructured":"Renner U, Gloddek J, Arzt E, Inoue K, Stalla GK (1997) Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT\/GF mouse pituitary tumor cells. Exp Clin Endocrinol Diabetes 105(6):345\u2013352. https:\/\/doi.org\/10.1055\/s-0029-1211777","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"1211_CR68","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0739-7240(98)00027-7","volume":"15","author":"U Renner","year":"1998","unstructured":"Renner U, Gloddek J, Pereda MP, Arzt E, Stalla GK (1998) Regulation and role of intrapituitary IL-6 production by folliculostellate cells. Domest Anim Endocrinol 15(5):353\u2013362","journal-title":"Domest Anim Endocrinol"},{"key":"1211_CR69","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fendo.2015.00141","volume":"6","author":"F Grizzi","year":"2015","unstructured":"Grizzi F, Borroni EM, Vacchini A, Qehajaj D, Liguori M, Stifter S et al (2015) Pituitary adenoma and the chemokine network: a systemic view. Front Endocrinol (Lausanne) 6:141. https:\/\/doi.org\/10.3389\/fendo.2015.00141","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1211_CR70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cytogfr.2009.11.007","volume":"21","author":"A Mantovani","year":"2010","unstructured":"Mantovani A, Savino B, Locati M, Zammataro L, Allavena P, Bonecchi R (2010) The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev 21(1):27\u201339. https:\/\/doi.org\/10.1016\/j.cytogfr.2009.11.007","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1\u20132","key":"1211_CR71","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jneuroim.2010.05.007","volume":"224","author":"F Marchesi","year":"2010","unstructured":"Marchesi F, Locatelli M, Solinas G, Erreni M, Allavena P, Mantovani A (2010) Role of CX3CR1\/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer. J Neuroimmunol 224(1\u20132):39\u201344. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.05.007","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1211_CR72","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1210\/edrv.18.2.0297","volume":"18","author":"D Ray","year":"1997","unstructured":"Ray D, Melmed S (1997) Pituitary cytokine and growth factor expression and action. Endocr Rev 18(2):206\u2013228. https:\/\/doi.org\/10.1210\/edrv.18.2.0297","journal-title":"Endocr Rev"},{"issue":"5","key":"1211_CR73","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000245928","volume":"72","author":"MR Haedo","year":"2009","unstructured":"Haedo MR, Gerez J, Fuertes M, Giacomini D, Paez-Pereda M, Labeur M et al (2009) Regulation of pituitary function by cytokines. Horm Res 72(5):266\u2013274. https:\/\/doi.org\/10.1159\/000245928","journal-title":"Horm Res"},{"issue":"1","key":"1211_CR74","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1006\/frne.1998.0176","volume":"20","author":"E Arzt","year":"1999","unstructured":"Arzt E, Pereda MP, Castro CP, Pagotto U, Renner U, Stalla GK (1999) Pathophysiological role of the cytokine network in the anterior pituitary gland. Front Neuroendocrinol 20(1):71\u201395. https:\/\/doi.org\/10.1006\/frne.1998.0176","journal-title":"Front Neuroendocrinol"},{"key":"1211_CR75","doi-asserted-by":"crossref","unstructured":"Barry S CE, Gadaleta E, Berney DM, Chelala C, Crnogorac-Jurcevic T, Gabrovska P, Korbonits M (2017) The role of the microenvironment in the invasive phenotype of aryl-hydrocarbon receptor interacting protein (AIP) mutation positive pituitary tumours. Endocr Rev","DOI":"10.1530\/endoabs.44.P156"},{"issue":"2","key":"1211_CR76","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1124\/mol.105.015255","volume":"69","author":"T Florio","year":"2006","unstructured":"Florio T, Casagrande S, Diana F, Bajetto A, Porcile C, Zona G et al (2006) Chemokine stromal cell-derived factor 1alpha induces proliferation and growth hormone release in GH4C1 rat pituitary adenoma cell line through multiple intracellular signals. Mol Pharmacol 69(2):539\u2013546. https:\/\/doi.org\/10.1124\/mol.105.015255","journal-title":"Mol Pharmacol"},{"key":"1211_CR77","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1196\/annals.1378.042","volume":"1090","author":"A Massa","year":"2006","unstructured":"Massa A, Casagrande S, Bajetto A, Porcile C, Barbieri F, Thellung S et al (2006) SDF-1 controls pituitary cell proliferation through the activation of ERK1\/2 and the Ca2+-dependent, cytosolic tyrosine kinase Pyk2. Ann N Y Acad Sci 1090:385\u2013398. https:\/\/doi.org\/10.1196\/annals.1378.042","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"1211_CR78","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1677\/JOE-08-0250","volume":"199","author":"Y Lee","year":"2008","unstructured":"Lee Y, Kim JM, Lee EJ (2008) Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation. J Endocrinol 199(2):191\u2013199. https:\/\/doi.org\/10.1677\/JOE-08-0250","journal-title":"J Endocrinol"},{"issue":"7","key":"1211_CR79","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3967\/0895-3988.2013.07.011","volume":"26","author":"B Xing","year":"2013","unstructured":"Xing B, Kong YG, Yao Y, Lian W, Wang RZ, Ren ZY (2013) Study on the expression levels of CXCR4, CXCL12, CD44, and CD147 and their potential correlation with invasive behaviors of pituitary adenomas. Biomed Environ Sci 26(7):592\u2013598. https:\/\/doi.org\/10.3967\/0895-3988.2013.07.011","journal-title":"Biomed Environ Sci"},{"issue":"3","key":"1211_CR80","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ghir.2011.03.005","volume":"21","author":"SD Vindelov","year":"2011","unstructured":"Vindelov SD, Hartoft-Nielsen ML, Rasmussen AK, Bendtzen K, Kosteljanetz M, Andersson AM et al (2011) Interleukin-8 production from human somatotroph adenoma cells is stimulated by interleukin-1beta and inhibited by growth hormone releasing hormone and somatostatin. Growth Horm IGF Res 21(3):134\u2013139. https:\/\/doi.org\/10.1016\/j.ghir.2011.03.005","journal-title":"Growth Horm IGF Res"},{"issue":"1","key":"1211_CR81","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1210\/jcem.78.1.8288702","volume":"78","author":"TH Jones","year":"1994","unstructured":"Jones TH, Daniels M, James RA, Justice SK, McCorkle R, Price A et al (1994) Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas. J Clin Endocrinol Metab 78(1):180\u2013187. https:\/\/doi.org\/10.1210\/jcem.78.1.8288702","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1211_CR82","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/modpathol.3880392","volume":"14","author":"R Kurotani","year":"2001","unstructured":"Kurotani R, Yasuda M, Oyama K, Egashira N, Sugaya M, Teramoto A et al (2001) Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor\u2019s signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas. Mod Pathol 14(8):791\u2013797. https:\/\/doi.org\/10.1038\/modpathol.3880392","journal-title":"Mod Pathol"},{"issue":"1","key":"1211_CR83","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/42.1.8263325","volume":"42","author":"B Velkeniers","year":"1994","unstructured":"Velkeniers B, Vergani P, Trouillas J, D\u2019Haens J, Hooghe RJ, Hooghe-Peters EL (1994) Expression of IL-6 mRNA in normal rat and human pituitaries and in human pituitary adenomas. J Histochem Cytochem 42(1):67\u201376. https:\/\/doi.org\/10.1177\/42.1.8263325","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"1211_CR84","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1210\/endo.132.1.8419142","volume":"132","author":"E Arzt","year":"1993","unstructured":"Arzt E, Buric R, Stelzer G, Stalla J, Sauer J, Renner U et al (1993) Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6. Endocrinology 132(1):459\u2013467. https:\/\/doi.org\/10.1210\/endo.132.1.8419142","journal-title":"Endocrinology"},{"issue":"3","key":"1211_CR85","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000125884","volume":"54","author":"K Lyson","year":"1991","unstructured":"Lyson K, McCann SM (1991) The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology 54(3):262\u2013266","journal-title":"Neuroendocrinology"},{"issue":"3","key":"1211_CR86","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1055\/s-2000-7887","volume":"108","author":"MP Pereda","year":"2000","unstructured":"Pereda MP, Lohrer P, Kovalovsky D, Perez Castro C, Goldberg V, Losa M et al (2000) Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas. Exp Clin Endocrinol Diabetes 108(3):202\u2013207","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"1211_CR87","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF03349706","volume":"18","author":"T Sawada","year":"1995","unstructured":"Sawada T, Koike K, Kanda Y, Ikegami H, Jikihara H, Maeda T et al (1995) Interleukin-6 stimulates cell proliferation of rat pituitary clonal cell lines in vitro. J Endocrinol Invest 18(2):83\u201390. https:\/\/doi.org\/10.1007\/BF03349706","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"1211_CR88","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1530\/eje.0.1510595","volume":"151","author":"M Graciarena","year":"2004","unstructured":"Graciarena M, Carbia-Nagashima A, Onofri C, Perez-Castro C, Giacomini D, Renner U et al (2004) Involvement of the gp130 cytokine transducer in MtT\/S pituitary somatotroph tumour development in an autocrine-paracrine model. Eur J Endocrinol 151(5):595\u2013604","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1211_CR89","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/en.2002-220891","volume":"144","author":"CP Castro","year":"2003","unstructured":"Castro CP, Giacomini D, Nagashima AC, Onofri C, Graciarena M, Kobayashi K et al (2003) Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells. Endocrinology 144(2):693\u2013700. https:\/\/doi.org\/10.1210\/en.2002-220891","journal-title":"Endocrinology"},{"issue":"5","key":"1211_CR90","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1530\/eje.0.1490455","volume":"149","author":"JO Thiele","year":"2003","unstructured":"Thiele JO, Lohrer P, Schaaf L, Feirer M, Stummer W, Losa M et al (2003) Functional in vitro studies on the role and regulation of interleukin-6 in human somatotroph pituitary adenomas. Eur J Endocrinol 149(5):455\u2013461","journal-title":"Eur J Endocrinol"},{"key":"1211_CR91","doi-asserted-by":"publisher","DOI":"10.4238\/gmr.15017502","author":"JL Wu","year":"2016","unstructured":"Wu JL, Qiao JY, Duan QH (2016) Significance of TNF-alpha and IL-6 expression in invasive pituitary adenomas. Genet Mol Res. https:\/\/doi.org\/10.4238\/gmr.15017502","journal-title":"Genet Mol Res"},{"key":"1211_CR92","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.mce.2016.07.025","volume":"436","author":"J Feng","year":"2016","unstructured":"Feng J, Yu SY, Li CZ, Li ZY, Zhang YZ (2016) Integrative proteomics and transcriptomics revealed that activation of the IL-6R\/JAK2\/STAT3\/MMP9 signaling pathway is correlated with invasion of pituitary null cell adenomas. Mol Cell Endocrinol 436:195\u2013203. https:\/\/doi.org\/10.1016\/j.mce.2016.07.025","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"1211_CR93","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1210\/endo.130.3.1311230","volume":"130","author":"CG Sweep","year":"1992","unstructured":"Sweep CG, van der Meer MJ, Hermus AR, Smals AG, van der Meer JW, Pesman GJ et al (1992) Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1 beta infusion: in vivo and in vitro studies. Endocrinology 130(3):1153\u20131164. https:\/\/doi.org\/10.1210\/endo.130.3.1311230","journal-title":"Endocrinology"},{"issue":"1\u20133","key":"1211_CR94","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0014-5793(04)00303-5","volume":"563","author":"D Kovalovsky","year":"2004","unstructured":"Kovalovsky D, Paez Pereda M, Labeur M, Renner U, Holsboer F, Stalla GK et al (2004) Nur77 induction and activation are necessary for interleukin-1 stimulation of proopiomelanocortin in AtT-20 corticotrophs. FEBS Lett 563(1\u20133):229\u2013233. https:\/\/doi.org\/10.1016\/S0014-5793(04)00303-5","journal-title":"FEBS Lett"},{"issue":"4","key":"1211_CR95","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000087160","volume":"81","author":"FY Gong","year":"2005","unstructured":"Gong FY, Deng JY, Shi YF (2005) Stimulatory effect of interleukin-1beta on growth hormone gene expression and growth hormone release from rat GH3 cells. Neuroendocrinology 81(4):217\u2013228. https:\/\/doi.org\/10.1159\/000087160","journal-title":"Neuroendocrinology"},{"issue":"5","key":"1211_CR96","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1172\/JCI116072","volume":"90","author":"E Arzt","year":"1992","unstructured":"Arzt E, Stelzer G, Renner U, Lange M, Muller OA, Stalla GK (1992) Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures. J Clin Invest 90(5):1944\u20131951. https:\/\/doi.org\/10.1172\/JCI116072","journal-title":"J Clin Invest"},{"issue":"2","key":"1211_CR97","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1210\/jcem-69-2-402","volume":"69","author":"KD Denicoff","year":"1989","unstructured":"Denicoff KD, Durkin TM, Lotze MT, Quinlan PE, Davis CL, Listwak SJ et al (1989) The neuroendocrine effects of interleukin-2 treatment. J Clin Endocrinol Metab 69(2):402\u2013410. https:\/\/doi.org\/10.1210\/jcem-69-2-402","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1211_CR98","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1073\/pnas.88.7.2961","volume":"88","author":"S Karanth","year":"1991","unstructured":"Karanth S, McCann SM (1991) Anterior pituitary hormone control by interleukin 2. Proc Natl Acad Sci U S A 88(7):2961\u20132965","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1211_CR99","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/BF02990062","volume":"3","author":"E Arzt","year":"1995","unstructured":"Arzt E, Sauer J, Buric R, Stalla J, Renner U, Stalla GK (1995) Characterization of Interleukin-2 (IL-2) receptor expression and action of IL-2 and IL-6 on normal anterior pituitary cell growth. Endocrine 3(2):113\u2013119. https:\/\/doi.org\/10.1007\/BF02990062","journal-title":"Endocrine"},{"issue":"6","key":"1211_CR100","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.mehy.2013.03.011","volume":"80","author":"L Qiu","year":"2013","unstructured":"Qiu L, Yang J, Wang H, Zhu Y, Wang Y, Wu Q (2013) Expression of T-helper-associated cytokines in the serum of pituitary adenoma patients preoperatively and postperatively. Med Hypotheses 80(6):781\u2013786. https:\/\/doi.org\/10.1016\/j.mehy.2013.03.011","journal-title":"Med Hypotheses"},{"issue":"3","key":"1211_CR101","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s11102-011-0292-5","volume":"14","author":"L Qiu","year":"2011","unstructured":"Qiu L, He D, Fan X, Li Z, Liao C, Zhu Y et al (2011) The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas. Pituitary 14(3):266\u2013275. https:\/\/doi.org\/10.1007\/s11102-011-0292-5","journal-title":"Pituitary"},{"issue":"22","key":"1211_CR102","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1158\/1078-0432.CCR-18-0472","volume":"24","author":"H Zhu","year":"2018","unstructured":"Zhu H, Guo J, Shen Y, Dong W, Gao H, Miao Y et al (2018) Functions and mechanisms of tumor necrosis factor-alpha and noncoding RNAs in bone-invasive pituitary adenomas. Clin Cancer Res 24(22):5757\u20135766. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0472","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1211_CR103","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1385\/EP:16:2:115","volume":"16","author":"K Kim","year":"2005","unstructured":"Kim K, Yoshida D, Teramoto A (2005) Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in pituitary adenomas. Endocr Pathol 16(2):115\u2013121","journal-title":"Endocr Pathol"},{"issue":"1","key":"1211_CR104","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1677\/joe.1.06992","volume":"191","author":"C Onofri","year":"2006","unstructured":"Onofri C, Theodoropoulou M, Losa M, Uhl E, Lange M, Arzt E et al (2006) Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours. J Endocrinol 191(1):249\u2013261. https:\/\/doi.org\/10.1677\/joe.1.06992","journal-title":"J Endocrinol"},{"issue":"5","key":"1211_CR105","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1210\/er.2002-0008","volume":"24","author":"HE Turner","year":"2003","unstructured":"Turner HE, Harris AL, Melmed S, Wass JA (2003) Angiogenesis in endocrine tumors. Endocr Rev 24(5):600\u2013632. https:\/\/doi.org\/10.1210\/er.2002-0008","journal-title":"Endocr Rev"},{"issue":"2","key":"1211_CR106","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/0006-291x(89)92678-8","volume":"161","author":"N Ferrara","year":"1989","unstructured":"Ferrara N, Henzel WJ (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161(2):851\u2013858. https:\/\/doi.org\/10.1016\/0006-291x(89)92678-8","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"1211_CR107","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1073\/pnas.84.16.5773","volume":"84","author":"N Ferrara","year":"1987","unstructured":"Ferrara N, Schweigerer L, Neufeld G, Mitchell R, Gospodarowicz D (1987) Pituitary follicular cells produce basic fibroblast growth factor. Proc Natl Acad Sci USA 84(16):5773\u20135777. https:\/\/doi.org\/10.1073\/pnas.84.16.5773","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1211_CR108","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1073\/pnas.89.2.698","volume":"89","author":"N Ferrara","year":"1992","unstructured":"Ferrara N, Winer J, Henzel WJ (1992) Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor. Proc Natl Acad Sci USA 89(2):698\u2013702. https:\/\/doi.org\/10.1073\/pnas.89.2.698","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4935","key":"1211_CR109","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1126\/science.2479986","volume":"246","author":"DW Leung","year":"1989","unstructured":"Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246(4935):1306\u20131309. https:\/\/doi.org\/10.1126\/science.2479986","journal-title":"Science"},{"issue":"2","key":"1211_CR110","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0002-9440(10)65284-4","volume":"154","author":"JE Nor","year":"1999","unstructured":"Nor JE, Christensen J, Mooney DJ, Polverini PJ (1999) Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154(2):375\u2013384. https:\/\/doi.org\/10.1016\/S0002-9440(10)65284-4","journal-title":"Am J Pathol"},{"issue":"2","key":"1211_CR111","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1530\/eje.1.01843","volume":"152","author":"SA Borg","year":"2005","unstructured":"Borg SA, Kerry KE, Royds JA, Battersby RD, Jones TH (2005) Correlation of VEGF production with IL1 alpha and IL6 secretion by human pituitary adenoma cells. Eur J Endocrinol 152(2):293\u2013300. https:\/\/doi.org\/10.1530\/eje.1.01843","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1211_CR112","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000054675","volume":"74","author":"P Lohrer","year":"2001","unstructured":"Lohrer P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto U et al (2001) Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro. Neuroendocrinology 74(2):95\u2013105","journal-title":"Neuroendocrinology"},{"issue":"9","key":"1211_CR113","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1210\/jc.2002-020309","volume":"87","author":"CJ McCabe","year":"2002","unstructured":"McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS et al (2002) Vascular endothelial growth factor, its receptor KDR\/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 87(9):4238\u20134244. https:\/\/doi.org\/10.1210\/jc.2002-020309","journal-title":"J Clin Endocrinol Metab"},{"issue":"398","key":"1211_CR114","first-page":"151","volume":"101","author":"J Komorowski","year":"2000","unstructured":"Komorowski J, Jankewicz J, Stepien H (2000) Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours. Cytobios 101(398):151\u2013159","journal-title":"Cytobios"},{"issue":"3","key":"1211_CR115","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF02738884","volume":"10","author":"RV Lloyd","year":"1999","unstructured":"Lloyd RV, Scheithauer BW, Kuroki T, Vidal S, Kovacs K, Stefaneanu L (1999) Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocr Pathol 10(3):229\u2013235","journal-title":"Endocr Pathol"},{"issue":"3","key":"1211_CR116","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s11102-012-0434-4","volume":"16","author":"R Sanchez-Ortiga","year":"2013","unstructured":"Sanchez-Ortiga R, Sanchez-Tejada L, Moreno-Perez O, Riesgo P, Niveiro M, Pico Alfonso AM (2013) Over-expression of vascular endothelial growth factor in pituitary adenomas is associated with extrasellar growth and recurrence. Pituitary 16(3):370\u2013377. https:\/\/doi.org\/10.1007\/s11102-012-0434-4","journal-title":"Pituitary"},{"issue":"10","key":"1211_CR117","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.humpath.2005.07.015","volume":"36","author":"M Niveiro","year":"2005","unstructured":"Niveiro M, Aranda FI, Peiro G, Alenda C, Pico A (2005) Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. Hum Pathol 36(10):1090\u20131095. https:\/\/doi.org\/10.1016\/j.humpath.2005.07.015","journal-title":"Hum Pathol"},{"issue":"5","key":"1211_CR118","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/jcm8050695","volume":"8","author":"M Sato","year":"2019","unstructured":"Sato M, Tamura R, Tamura H, Mase T, Kosugi K, Morimoto Y et al (2019) Analysis of tumor angiogenesis and immune microenvironment in non-functional pituitary endocrine tumors. J Clin Med 8(5):10. https:\/\/doi.org\/10.3390\/jcm8050695","journal-title":"J Clin Med"},{"issue":"2","key":"1211_CR119","first-page":"23","volume":"53","author":"K Arita","year":"2004","unstructured":"Arita K, Kurisu K, Tominaga A, Sugiyama K, Eguchi K, Hama S et al (2004) Relationship between intratumoral hemorrhage and overexpression of vascular endothelial growth factor (VEGF) in pituitary adenoma. Hiroshima J Med Sci 53(2):23\u201327","journal-title":"Hiroshima J Med Sci"},{"key":"1211_CR120","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fendo.2018.00107","volume":"9","author":"P Gupta","year":"2018","unstructured":"Gupta P, Dutta P (2018) Landscape of molecular events in pituitary apoplexy. Front Endocrinol (Lausanne) 9:107. https:\/\/doi.org\/10.3389\/fendo.2018.00107","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1211_CR121","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0967-5868(03)00013-4","volume":"10","author":"S Fukui","year":"2003","unstructured":"Fukui S, Otani N, Nawashiro H, Yano A, Nomura N, Tokumaru AM et al (2003) The association of the expression of vascular endothelial growth factor with the cystic component and haemorrhage in pituitary adenoma. J Clin Neurosci 10(3):320\u2013324","journal-title":"J Clin Neurosci"},{"issue":"22","key":"1211_CR122","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.18632\/oncotarget.26775","volume":"10","author":"G Yagnik","year":"2019","unstructured":"Yagnik G, Rutowski MJ, Shah SS, Aghi MK (2019) Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes. Oncotarget 10(22):2212\u20132223. https:\/\/doi.org\/10.18632\/oncotarget.26775","journal-title":"Oncotarget"},{"issue":"4","key":"1211_CR123","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3892\/ijo.2017.4120","volume":"51","author":"M Spoletini","year":"2017","unstructured":"Spoletini M, Taurone S, Tombolini M, Minni A, Altissimi G, Wierzbicki V et al (2017) Trophic and neurotrophic factors in human pituitary adenomas (review). Int J Oncol 51(4):1014\u20131024. https:\/\/doi.org\/10.3892\/ijo.2017.4120","journal-title":"Int J Oncol"},{"key":"1211_CR124","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000079039","volume":"32","author":"U Renner","year":"2004","unstructured":"Renner U, Paez-Pereda M, Arzt E, Stalla GK (2004) Growth factors and cytokines: function and molecular regulation in pituitary adenomas. Front Horm Res 32:96\u2013109","journal-title":"Front Horm Res"},{"issue":"3","key":"1211_CR125","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1750-3639.2001.tb00405.x","volume":"11","author":"S Ezzat","year":"2001","unstructured":"Ezzat S (2001) The role of hormones, growth factors and their receptors in pituitary tumorigenesis. Brain Pathol 11(3):356\u2013370","journal-title":"Brain Pathol"},{"issue":"8","key":"1211_CR126","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/BF03349601","volume":"13","author":"S Ezzat","year":"1990","unstructured":"Ezzat S, Melmed S (1990) The role of growth factors in the pituitary. J Endocrinol Invest 13(8):691\u2013698. https:\/\/doi.org\/10.1007\/BF03349601","journal-title":"J Endocrinol Invest"},{"issue":"3\u20134","key":"1211_CR127","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1023\/A:1009996712678","volume":"1","author":"C Missale","year":"1999","unstructured":"Missale C, Fiorentini C, Finardi A, Spano P (1999) Growth factors in pituitary tumors. Pituitary 1(3\u20134):153\u2013158","journal-title":"Pituitary"},{"issue":"4","key":"1211_CR128","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1385\/EP:11:4:295","volume":"11","author":"W Saeger","year":"2000","unstructured":"Saeger W (2000) Expression of growth factors in normal and neoplastic pituitary tissues. Endocr Pathol 11(4):295\u2013300","journal-title":"Endocr Pathol"},{"issue":"1\u20132","key":"1211_CR129","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0303-7207(02)00279-4","volume":"197","author":"A Spada","year":"2002","unstructured":"Spada A, Lania A (2002) Growth factors and human pituitary adenomas. Mol Cell Endocrinol 197(1\u20132):63\u201368. https:\/\/doi.org\/10.1016\/s0303-7207(02)00279-4","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"1211_CR130","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1365-2265.1996.d01-1554.x","volume":"45","author":"VL Green","year":"1996","unstructured":"Green VL, Atkin SL, Speirs V, Jeffreys RV, Landolt AM, Mathew B et al (1996) Cytokine expression in human anterior pituitary adenomas. Clin Endocrinol (Oxf) 45(2):179\u2013185","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"1211_CR131","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1530\/JOE-15-0451","volume":"228","author":"MV Recouvreux","year":"2016","unstructured":"Recouvreux MV, Camilletti MA, Rifkin DB, Diaz-Torga G (2016) The pituitary TGFbeta1 system as a novel target for the treatment of resistant prolactinomas. J Endocrinol 228(3):R73-83. https:\/\/doi.org\/10.1530\/JOE-15-0451","journal-title":"J Endocrinol"},{"issue":"11","key":"1211_CR132","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1210\/mend.6.11.1480172","volume":"6","author":"DK Sarkar","year":"1992","unstructured":"Sarkar DK, Kim KH, Minami S (1992) Transforming growth factor-beta 1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growth. Mol Endocrinol 6(11):1825\u20131833. https:\/\/doi.org\/10.1210\/mend.6.11.1480172","journal-title":"Mol Endocrinol"},{"issue":"1","key":"1211_CR133","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1677\/joe.0.1490019","volume":"149","author":"A De","year":"1996","unstructured":"De A, Morgan TE, Speth RC, Boyadjieva N, Sarkar DK (1996) Pituitary lactotrope expresses transforming growth factor beta (TGF beta) type II receptor mRNA and protein and contains 125I-TGF beta 1 binding sites. J Endocrinol 149(1):19\u201327","journal-title":"J Endocrinol"},{"issue":"1","key":"1211_CR134","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s12020-008-9060-3","volume":"33","author":"KH Ruebel","year":"2008","unstructured":"Ruebel KH, Leontovich AA, Tanizaki Y, Jin L, Stilling GA, Zhang S et al (2008) Effects of TGFbeta1 on gene expression in the HP75 human pituitary tumor cell line identified by gene expression profiling. Endocrine 33(1):62\u201376. https:\/\/doi.org\/10.1007\/s12020-008-9060-3","journal-title":"Endocrine"},{"issue":"10","key":"1211_CR135","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00262-020-02611-x","volume":"69","author":"V Suteau","year":"2020","unstructured":"Suteau V, Collin A, Menei P, Rodien P, Rousselet MC, Briet C (2020) Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor. Cancer Immunol Immunother 69(10):2053\u20132061. https:\/\/doi.org\/10.1007\/s00262-020-02611-x","journal-title":"Cancer Immunol Immunother"},{"key":"1211_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082831","author":"S Uraki","year":"2020","unstructured":"Uraki S, Ariyasu H, Doi A, Takeshima K, Morita S, Inaba H et al (2020) MSH6\/2 and PD-L1 expressions are associated with tumor growth and invasiveness in silent pituitary adenoma subtypes. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21082831","journal-title":"Int J Mol Sci"},{"key":"1211_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.726448","volume":"12","author":"Z Xi","year":"2021","unstructured":"Xi Z, Jones PS, Mikamoto M, Jiang X, Faje AT, Nie C et al (2021) The upregulation of molecules related to tumor immune escape in human pituitary adenomas. Front Endocrinol (Lausanne) 12:726448. https:\/\/doi.org\/10.3389\/fendo.2021.726448","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1211_CR138","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1210\/er.2012-1013","volume":"34","author":"A Beckers","year":"2013","unstructured":"Beckers A, Aaltonen LA, Daly AF, Karhu A (2013) Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 34(2):239\u2013277. https:\/\/doi.org\/10.1210\/er.2012-1013","journal-title":"Endocr Rev"},{"issue":"20","key":"1211_CR139","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1158\/1078-0432.CCR-16-0452","volume":"22","author":"F Caimari","year":"2016","unstructured":"Caimari F, Korbonits M (2016) Novel genetic causes of pituitary adenomas. Clin Cancer Res 22(20):5030\u20135042. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0452","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1211_CR140","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1210\/clinem\/dgaa040","volume":"105","author":"P Marques","year":"2020","unstructured":"Marques P, Caimari F, Hernandez-Ramirez LC, Collier D, Iacovazzo D, Ronaldson A et al (2020) Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors. J Clin Endocrinol Metab. 105(6):10. https:\/\/doi.org\/10.1210\/clinem\/dgaa040","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"1211_CR141","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25(12):677\u2013686. https:\/\/doi.org\/10.1016\/j.it.2004.09.015","journal-title":"Trends Immunol"},{"issue":"2","key":"1211_CR142","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.molimm.2014.07.013","volume":"63","author":"ML Lennard Richard","year":"2015","unstructured":"Lennard Richard ML, Nowling TK, Brandon D, Watson DK, Zhang XK (2015) Fli-1 controls transcription from the MCP-1 gene promoter, which may provide a novel mechanism for chemokine and cytokine activation. Mol Immunol 63(2):566\u2013573. https:\/\/doi.org\/10.1016\/j.molimm.2014.07.013","journal-title":"Mol Immunol"},{"issue":"6","key":"1211_CR143","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.4049\/jimmunol.1302779","volume":"193","author":"ML Lennard Richard","year":"2014","unstructured":"Lennard Richard ML, Sato S, Suzuki E, Williams S, Nowling TK, Zhang XK (2014) The Fli-1 transcription factor regulates the expression of CCL5\/RANTES. J Immunol 193(6):2661\u20132668. https:\/\/doi.org\/10.4049\/jimmunol.1302779","journal-title":"J Immunol"},{"issue":"16","key":"1211_CR144","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1038\/onc.2014.162","volume":"34","author":"Y Li","year":"2015","unstructured":"Li Y, Luo H, Liu T, Zacksenhaus E, Ben-David Y (2015) The ets transcription factor Fli-1 in development, cancer and disease. Oncogene 34(16):2022\u20132031. https:\/\/doi.org\/10.1038\/onc.2014.162","journal-title":"Oncogene"},{"key":"1211_CR145","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.wneu.2018.11.021","volume":"123","author":"F Cai","year":"2019","unstructured":"Cai F, Hong Y, Xu J, Wu Q, Reis C, Yan W et al (2019) A novel mutation of aryl hydrocarbon receptor interacting protein gene associated with familial isolated pituitary adenoma mediates tumor invasion and growth hormone hypersecretion. World Neurosurg 123:e45\u2013e59. https:\/\/doi.org\/10.1016\/j.wneu.2018.11.021","journal-title":"World Neurosurg"},{"issue":"10","key":"1211_CR146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164131","volume":"11","author":"T Fukuda","year":"2016","unstructured":"Fukuda T, Tanaka T, Hamaguchi Y, Kawanami T, Nomiyama T, Yanase T (2016) Augmented growth hormone secretion and Stat3 phosphorylation in an aryl hydrocarbon receptor interacting protein (AIP)-disrupted somatotroph cell line. PLoS ONE 11(10):e0164131. https:\/\/doi.org\/10.1371\/journal.pone.0164131","journal-title":"PLoS ONE"},{"issue":"5","key":"1211_CR147","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.smim.2015.10.002","volume":"27","author":"M Cella","year":"2015","unstructured":"Cella M, Colonna M (2015) Aryl hydrocarbon receptor: linking environment to immunity. Semin Immunol 27(5):310\u2013314. https:\/\/doi.org\/10.1016\/j.smim.2015.10.002","journal-title":"Semin Immunol"},{"issue":"6","key":"1211_CR148","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/intimm\/dxt011","volume":"25","author":"NT Nguyen","year":"2013","unstructured":"Nguyen NT, Hanieh H, Nakahama T, Kishimoto T (2013) The roles of aryl hydrocarbon receptor in immune responses. Int Immunol 25(6):335\u2013343. https:\/\/doi.org\/10.1093\/intimm\/dxt011","journal-title":"Int Immunol"},{"key":"1211_CR149","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev-immunol-032713-120245","volume":"32","author":"B Stockinger","year":"2014","unstructured":"Stockinger B, Di Meglio P, Gialitakis M, Duarte JH (2014) The aryl hydrocarbon receptor: multitasking in the immune system. Annu Rev Immunol 32:403\u2013432. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120245","journal-title":"Annu Rev Immunol"},{"issue":"1\u20132","key":"1211_CR150","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","volume":"168","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Lenardo MJ, Baltimore D (2017) 30 years of NF-kappaB: a blossoming of relevance to human pathobiology. Cell 168(1\u20132):37\u201357. https:\/\/doi.org\/10.1016\/j.cell.2016.12.012","journal-title":"Cell"},{"issue":"23","key":"1211_CR151","doi-asserted-by":"publisher","first-page":"14729","DOI":"10.1074\/jbc.M114.633065","volume":"290","author":"Q Zhou","year":"2015","unstructured":"Zhou Q, Lavorgna A, Bowman M, Hiscott J, Harhaj EW (2015) Aryl hydrocarbon receptor interacting protein targets IRF7 to suppress antiviral signaling and the induction of type I interferon. J Biol Chem 290(23):14729\u201314739. https:\/\/doi.org\/10.1074\/jbc.M114.633065","journal-title":"J Biol Chem"},{"issue":"4","key":"1211_CR152","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/s1043-2760(98)00043-5","volume":"9","author":"S Melmed","year":"1998","unstructured":"Melmed S (1998) gp130-related cytokines and their receptors in the pituitary. Trends Endocrinol Metab 9(4):155\u2013161. https:\/\/doi.org\/10.1016\/s1043-2760(98)00043-5","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"1211_CR153","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1172\/JCI117779","volume":"95","author":"S Akita","year":"1995","unstructured":"Akita S, Webster J, Ren SG, Takino H, Said J, Zand O et al (1995) Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J Clin Invest 95(3):1288\u20131298. https:\/\/doi.org\/10.1172\/JCI117779","journal-title":"J Clin Invest"},{"issue":"5","key":"1211_CR154","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1210\/endo.143.5.8861","volume":"143","author":"V Chesnokova","year":"2002","unstructured":"Chesnokova V, Melmed S (2002) Minireview: neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 143(5):1571\u20131574. https:\/\/doi.org\/10.1210\/endo.143.5.8861","journal-title":"Endocrinology"},{"issue":"11","key":"1211_CR155","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1210\/mend.12.11.0200","volume":"12","author":"H Yano","year":"1998","unstructured":"Yano H, Readhead C, Nakashima M, Ren SG, Melmed S (1998) Pituitary-directed leukemia inhibitory factor transgene causes Cushing\u2019s syndrome: neuro-immune-endocrine modulation of pituitary development. Mol Endocrinol 12(11):1708\u20131720. https:\/\/doi.org\/10.1210\/mend.12.11.0200","journal-title":"Mol Endocrinol"},{"issue":"10","key":"1211_CR156","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1172\/JCI119430","volume":"99","author":"S Akita","year":"1997","unstructured":"Akita S, Readhead C, Stefaneanu L, Fine J, Tampanaru-Sarmesiu A, Kovacs K et al (1997) Pituitary-directed leukemia inhibitory factor transgene forms Rathke\u2019s cleft cysts and impairs adult pituitary function. A model for human pituitary Rathke\u2019s cysts. J Clin Invest. 99(10):2462\u20132469. https:\/\/doi.org\/10.1172\/JCI119430","journal-title":"J Clin Invest."},{"key":"1211_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010151","author":"Q Yang","year":"2019","unstructured":"Yang Q, Wang Y, Zhang S, Tang J, Li F, Yin J et al (2019) Biomarker discovery for immunotherapy of pituitary adenomas: enhanced robustness and prediction ability by modern computational tools. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20010151","journal-title":"Int J Mol Sci"},{"key":"1211_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.627117","volume":"12","author":"J Guo","year":"2021","unstructured":"Guo J, Fang Q, Liu Y, Xie W, Li C, Zhang Y (2021) Screening and identification of key microenvironment-related genes in non-functioning pituitary adenoma. Front Genet 12:627117. https:\/\/doi.org\/10.3389\/fgene.2021.627117","journal-title":"Front Genet"},{"issue":"10","key":"1211_CR159","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/jnen\/nlx072","volume":"76","author":"TE Richardson","year":"2017","unstructured":"Richardson TE, Shen ZJ, Kanchwala M, Xing C, Filatenkov A, Shang P et al (2017) Aggressive behavior in silent subtype III pituitary adenomas may depend on suppression of local immune response: a whole transcriptome analysis. J Neuropathol Exp Neurol 76(10):874\u2013882. https:\/\/doi.org\/10.1093\/jnen\/nlx072","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"1211_CR160","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1172\/JCI20401","volume":"112","author":"S Melmed","year":"2003","unstructured":"Melmed S (2003) Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 112(11):1603\u20131618. https:\/\/doi.org\/10.1172\/JCI20401","journal-title":"J Clin Invest"},{"issue":"4","key":"1211_CR161","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pages F, Sautes-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12(4):298\u2013306. https:\/\/doi.org\/10.1038\/nrc3245","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1211_CR162","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00418-008-0527-3","volume":"130","author":"MA Le Bitoux","year":"2008","unstructured":"Le Bitoux MA, Stamenkovic I (2008) Tumor-host interactions: the role of inflammation. Histochem Cell Biol 130(6):1079\u20131090. https:\/\/doi.org\/10.1007\/s00418-008-0527-3","journal-title":"Histochem Cell Biol"},{"key":"1211_CR163","first-page":"16","volume":"8","author":"R Uppaluri","year":"2008","unstructured":"Uppaluri R, Dunn GP, Lewis JS Jr (2008) Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers. Cancer Immun 8:16","journal-title":"Cancer Immun"},{"issue":"16","key":"1211_CR164","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1158\/1078-0432.CCR-07-4717","volume":"14","author":"F Barbieri","year":"2008","unstructured":"Barbieri F, Bajetto A, Stumm R, Pattarozzi A, Porcile C, Zona G et al (2008) Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine\/paracrine cell proliferation in human pituitary adenomas. Clin Cancer Res 14(16):5022\u20135032. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4717","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1211_CR165","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s004280000373","volume":"438","author":"S Vidal","year":"2001","unstructured":"Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloyd RV (2001) Microvessel density in pituitary adenomas and carcinomas. Virchows Arch 438(6):595\u2013602. https:\/\/doi.org\/10.1007\/s004280000373","journal-title":"Virchows Arch"},{"issue":"5","key":"1211_CR166","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6(5):392\u2013401. https:\/\/doi.org\/10.1038\/nrc1877","journal-title":"Nat Rev Cancer"},{"key":"1211_CR167","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/608497","volume":"2014","author":"C Cristina","year":"2014","unstructured":"Cristina C, Luque GM, Demarchi G, Lopez Vicchi F, Zubeldia-Brenner L, Perez Millan MI et al (2014) Angiogenesis in pituitary adenomas: human studies and new mutant mouse models. Int J Endocrinol 2014:608497. https:\/\/doi.org\/10.1155\/2014\/608497","journal-title":"Int J Endocrinol"},{"issue":"7347","key":"1211_CR168","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298\u2013307. https:\/\/doi.org\/10.1038\/nature10144","journal-title":"Nature"},{"issue":"2","key":"1211_CR169","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF02739874","volume":"6","author":"M Jugenburg","year":"1995","unstructured":"Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW (1995) Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: a quantitative morphologic study. Endocr Pathol 6(2):115\u2013124","journal-title":"Endocr Pathol"},{"issue":"3","key":"1211_CR170","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1210\/jcem.85.3.6485","volume":"85","author":"HE Turner","year":"2000","unstructured":"Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA (2000) Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab 85(3):1159\u20131162. https:\/\/doi.org\/10.1210\/jcem.85.3.6485","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1211_CR171","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1385\/EP:11:3:215","volume":"11","author":"S Vidal","year":"2000","unstructured":"Vidal S, Scheithauer BW, Kovacs K (2000) Vascularity in nontumorous human pituitaries and incidental microadenomas: a morphometric study. Endocr Pathol 11(3):215\u2013227","journal-title":"Endocr Pathol"},{"issue":"3","key":"1211_CR172","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s12020-020-02478-z","volume":"70","author":"P Marques","year":"2020","unstructured":"Marques P, Barry S, Carlsen E, Collier D, Ronaldson A, Dorward N et al (2020) The role of the tumour microenvironment in the angiogenesis of pituitary tumours. Endocrine 70(3):593\u2013606. https:\/\/doi.org\/10.1007\/s12020-020-02478-z","journal-title":"Endocrine"},{"issue":"8","key":"1211_CR173","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1054\/bjoc.1999.1074","volume":"82","author":"HE Turner","year":"2000","unstructured":"Turner HE, Nagy Z, Gatter KC, Esiri MM, Wass JA, Harris AL (2000) Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour. Br J Cancer 82(8):1441\u20131445. https:\/\/doi.org\/10.1054\/bjoc.1999.1074","journal-title":"Br J Cancer"},{"issue":"4","key":"1211_CR174","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1385\/EP:11:4:341","volume":"11","author":"L Stefaneanu","year":"2000","unstructured":"Stefaneanu L, Kovacs K, Scheithauer BW, Kontogeorgos G, Riehle DL, Sebo TJ et al (2000) Effect of dopamine agonists on lactotroph adenomas of the human pituitary. Endocr Pathol 11(4):341\u2013352","journal-title":"Endocr Pathol"},{"issue":"2","key":"1211_CR175","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1677\/joe.0.1650475","volume":"165","author":"HE Turner","year":"2000","unstructured":"Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA (2000) Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome. J Endocrinol 165(2):475\u2013481","journal-title":"J Endocrinol"},{"issue":"2","key":"1211_CR176","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3171\/jns.1987.67.2.0192","volume":"67","author":"PD Lees","year":"1987","unstructured":"Lees PD, Pickard JD (1987) Hyperprolactinemia, intrasellar pituitary tissue pressure, and the pituitary stalk compression syndrome. J Neurosurg 67(2):192\u2013196. https:\/\/doi.org\/10.3171\/jns.1987.67.2.0192","journal-title":"J Neurosurg"},{"issue":"6","key":"1211_CR177","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/BF01606873","volume":"421","author":"MR Farnoud","year":"1992","unstructured":"Farnoud MR, Lissak B, Kujas M, Peillon F, Racadot J, Li JY (1992) Specific alterations of the basement membrane and stroma antigens in human pituitary tumours in comparison with the normal anterior pituitary. An immunocytochemical study. Virchows Arch A Pathol Anat Histopathol. 421(6):449\u2013455","journal-title":"Virchows Arch A Pathol Anat Histopathol."},{"issue":"1","key":"1211_CR178","first-page":"109","volume":"67","author":"J Schechter","year":"1972","unstructured":"Schechter J (1972) Ultrastructural changes in the capillary bed of human pituitary tumors. Am J Pathol 67(1):109\u2013126","journal-title":"Am J Pathol"},{"issue":"14","key":"1211_CR179","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1073\/pnas.81.14.4549","volume":"81","author":"KA Elias","year":"1984","unstructured":"Elias KA, Weiner RI (1984) Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proc Natl Acad Sci U S A 81(14):4549\u20134553. https:\/\/doi.org\/10.1073\/pnas.81.14.4549","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1211_CR180","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000123987","volume":"39","author":"F Monnet","year":"1984","unstructured":"Monnet F, Elias KA, Fagin K, Neill A, Goldsmith P, Weiner RI (1984) Formation of a direct arterial blood supply to the anterior pituitary gland following complete or partial interruption of the hypophyseal portal vessels. Neuroendocrinology 39(3):251\u2013255. https:\/\/doi.org\/10.1159\/000123987","journal-title":"Neuroendocrinology"},{"issue":"2","key":"1211_CR181","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"B De Craene","year":"2013","unstructured":"De Craene B, Berx G (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13(2):97\u2013110. https:\/\/doi.org\/10.1038\/nrc3447","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"1211_CR182","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1158\/0008-5472.CAN-04-3545","volume":"65","author":"B De Craene","year":"2005","unstructured":"De Craene B, Gilbert B, Stove C, Bruyneel E, van Roy F, Berx G (2005) The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res 65(14):6237\u20136244. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3545","journal-title":"Cancer Res"},{"issue":"5","key":"1211_CR183","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871\u2013890. https:\/\/doi.org\/10.1016\/j.cell.2009.11.007","journal-title":"Cell"},{"issue":"10","key":"1211_CR184","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1210\/jc.2017-01000","volume":"102","author":"AL Brittain","year":"2017","unstructured":"Brittain AL, Basu R, Qian Y, Kopchick JJ (2017) Growth hormone and the epithelial-to-mesenchymal transition. J Clin Endocrinol Metab 102(10):3662\u20133673. https:\/\/doi.org\/10.1210\/jc.2017-01000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1211_CR185","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2265.2007.03065.x","volume":"68","author":"SL Fougner","year":"2008","unstructured":"Fougner SL, Borota OC, Berg JP, Hald JK, Ramm-Pettersen J, Bollerslev J (2008) The clinical response to somatostatin analogues in acromegaly correlates to the somatostatin receptor subtype 2a protein expression of the adenoma. Clin Endocrinol (Oxf) 68(3):458\u2013465. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03065.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"1211_CR186","doi-asserted-by":"publisher","first-page":"E1506","DOI":"10.1210\/jc.2012-1760","volume":"97","author":"T Lekva","year":"2012","unstructured":"Lekva T, Berg JP, Fougner SL, Olstad OK, Ueland T, Bollerslev J (2012) Gene expression profiling identifies ESRP1 as a potential regulator of epithelial mesenchymal transition in somatotroph adenomas from a large cohort of patients with acromegaly. J Clin Endocrinol Metab 97(8):E1506\u2013E1514. https:\/\/doi.org\/10.1210\/jc.2012-1760","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1211_CR187","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1111\/jcmm.13851","volume":"23","author":"E Venegas-Moreno","year":"2019","unstructured":"Venegas-Moreno E, Flores-Martinez A, Dios E, Vazquez-Borrego MC, Ibanez-Costa A, Madrazo-Atutxa A et al (2019) E-cadherin expression is associated with somatostatin analogue response in acromegaly. J Cell Mol Med 23(5):3088\u20133096. https:\/\/doi.org\/10.1111\/jcmm.13851","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1211_CR188","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou M, Villa C, Armignacco R, Jouinot A, Raffin-Sanson ML, Septier A et al (2020) Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37(1):123\u2013134. https:\/\/doi.org\/10.1016\/j.ccell.2019.11.002","journal-title":"Cancer Cell"},{"issue":"8","key":"1211_CR189","doi-asserted-by":"publisher","first-page":"E1237","DOI":"10.1210\/jc.2010-3040","volume":"96","author":"W Zhou","year":"2011","unstructured":"Zhou W, Song Y, Xu H, Zhou K, Zhang W, Chen J et al (2011) In nonfunctional pituitary adenomas, estrogen receptors and slug contribute to development of invasiveness. J Clin Endocrinol Metab 96(8):E1237\u2013E1245. https:\/\/doi.org\/10.1210\/jc.2010-3040","journal-title":"J Clin Endocrinol Metab"},{"key":"1211_CR190","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13052","author":"P Marques","year":"2021","unstructured":"Marques P, Barry S, Carlsen E, Collier D, Ronaldson A, Grieve J et al (2021) The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours. J Neuroendocrinol. https:\/\/doi.org\/10.1111\/jne.13052","journal-title":"J Neuroendocrinol"},{"issue":"10","key":"1211_CR191","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1210\/jc.2018-01347","volume":"103","author":"AL Lin","year":"2018","unstructured":"Lin AL, Jonsson P, Tabar V, Yang TJ, Cuaron J, Beal K et al (2018) Marked response of a hypermutated ACTH-secreting pituitary carcinoma to ipilimumab and nivolumab. J Clin Endocrinol Metab 103(10):3925\u20133930. https:\/\/doi.org\/10.1210\/jc.2018-01347","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1211_CR192","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/CAD.0000000000000856","volume":"31","author":"M Caccese","year":"2020","unstructured":"Caccese M, Barbot M, Ceccato F, Padovan M, Gardiman MP, Fassan M et al (2020) Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab. Anticancer Drugs 31(2):199\u2013204. https:\/\/doi.org\/10.1097\/CAD.0000000000000856","journal-title":"Anticancer Drugs"},{"issue":"3","key":"1211_CR193","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/jpm10030088","volume":"10","author":"C Duhamel","year":"2020","unstructured":"Duhamel C, Ilie MD, Salle H, Nassouri AS, Gaillard S, Deluche E et al (2020) Immunotherapy in corticotroph and lactotroph aggressive tumors and carcinomas: two case reports and a review of the literature. J Pers Med 10(3):10. https:\/\/doi.org\/10.3390\/jpm10030088","journal-title":"J Pers Med"},{"key":"1211_CR194","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001532","author":"N Majd","year":"2020","unstructured":"Majd N, Waguespack SG, Janku F, Fu S, Penas-Prado M, Xu M et al (2020) Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-001532","journal-title":"J Immunother Cancer"},{"issue":"1","key":"1211_CR195","doi-asserted-by":"publisher","first-page":"K1","DOI":"10.1530\/EJE-20-0151","volume":"184","author":"B Sol","year":"2021","unstructured":"Sol B, de Filette JMK, Awada G, Raeymaeckers S, Aspeslagh S, Andreescu CE et al (2021) Immune checkpoint inhibitor therapy for ACTH-secreting pituitary carcinoma: a new emerging treatment? Eur J Endocrinol 184(1):K1\u2013K5. https:\/\/doi.org\/10.1530\/EJE-20-0151","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1211_CR196","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1210\/jc.2019-00432","volume":"104","author":"P Dutta","year":"2019","unstructured":"Dutta P, Reddy KS, Rai A, Madugundu AK, Solanki HS, Bhansali A et al (2019) Surgery, octreotide, temozolomide, bevacizumab, radiotherapy, and pegvisomant treatment of an AIP mutationpositive child. J Clin Endocrinol Metab 104(8):3539\u20133544. https:\/\/doi.org\/10.1210\/jc.2019-00432","journal-title":"J Clin Endocrinol Metab"},{"key":"1211_CR197","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3389\/fendo.2018.00453","volume":"9","author":"P Gupta","year":"2018","unstructured":"Gupta P, Rai A, Mukherjee KK, Sachdeva N, Radotra BD, Punia RPS et al (2018) Imatinib inhibits GH secretion from somatotropinomas. Front Endocrinol (Lausanne) 9:453. https:\/\/doi.org\/10.3389\/fendo.2018.00453","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1211_CR198","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1210\/en.2010-0642","volume":"152","author":"JM Kim","year":"2011","unstructured":"Kim JM, Lee YH, Ku CR, Lee EJ (2011) The cyclic pentapeptide d-Arg3FC131, a CXCR4 antagonist, induces apoptosis of somatotrope tumor and inhibits tumor growth in nude mice. Endocrinology 152(2):536\u2013544. https:\/\/doi.org\/10.1210\/en.2010-0642","journal-title":"Endocrinology"},{"issue":"4","key":"1211_CR199","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00280-013-2099-8","volume":"71","author":"SK Sandhu","year":"2013","unstructured":"Sandhu SK, Papadopoulos K, Fong PC, Patnaik A, Messiou C, Olmos D et al (2013) A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors. Cancer Chemother Pharmacol 71(4):1041\u20131050. https:\/\/doi.org\/10.1007\/s00280-013-2099-8","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"1211_CR200","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s40425-019-0706-x","volume":"7","author":"M Bilusic","year":"2019","unstructured":"Bilusic M, Heery CR, Collins JM, Donahue RN, Palena C, Madan RA et al (2019) Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors. J Immunother Cancer 7(1):240. https:\/\/doi.org\/10.1186\/s40425-019-0706-x","journal-title":"J Immunother Cancer"},{"key":"1211_CR201","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.785050","volume":"12","author":"C Han","year":"2021","unstructured":"Han C, Lin S, Lu X, Xue L, Wu ZB (2021) Tumor-associated macrophages: new horizons for pituitary adenoma researches. Front Endocrinol (Lausanne) 12:785050. https:\/\/doi.org\/10.3389\/fendo.2021.785050","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1211_CR202","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/jcm11010124","volume":"11","author":"B Voellger","year":"2021","unstructured":"Voellger B, Zhang Z, Benzel J, Wang J, Lei T, Nimsky C et al (2021) Targeting aggressive pituitary adenomas at the molecular level-a review. J Clin Med 11(1):10. https:\/\/doi.org\/10.3390\/jcm11010124","journal-title":"J Clin Med"},{"issue":"3","key":"1211_CR203","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1530\/JOE-17-0254","volume":"235","author":"A Ibanez-Costa","year":"2017","unstructured":"Ibanez-Costa A, Korbonits M (2017) AIP and the somatostatin system in pituitary tumours. J Endocrinol 235(3):R101\u2013R116. https:\/\/doi.org\/10.1530\/JOE-17-0254","journal-title":"J Endocrinol"},{"issue":"6","key":"1211_CR204","doi-asserted-by":"publisher","first-page":"735","DOI":"10.15252\/emmm.201404346","volume":"7","author":"C Duluc","year":"2015","unstructured":"Duluc C, Moatassim-Billah S, Chalabi-Dchar M, Perraud A, Samain R, Breibach F et al (2015) Pharmacological targeting of the protein synthesis mTOR\/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance. EMBO Mol Med 7(6):735\u2013753. https:\/\/doi.org\/10.15252\/emmm.201404346","journal-title":"EMBO Mol Med"},{"issue":"1","key":"1211_CR205","first-page":"89","volume":"10","author":"A Andoh","year":"2002","unstructured":"Andoh A, Hata K, Shimada M, Fujino S, Tasaki K, Bamba S et al (2002) Inhibitory effects of somatostatin on tumor necrosis factor-alpha-induced interleukin-6 secretion in human pancreatic periacinar myofibroblasts. Int J Mol Med 10(1):89\u201393","journal-title":"Int J Mol Med"},{"issue":"1","key":"1211_CR206","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1006\/bbrc.1997.6513","volume":"235","author":"M Grimaldi","year":"1997","unstructured":"Grimaldi M, Florio T, Schettini G (1997) Somatostatin inhibits interleukin 6 release from rat cortical type I astrocytes via the inhibition of adenylyl cyclase. Biochem Biophys Res Commun 235(1):242\u2013248. https:\/\/doi.org\/10.1006\/bbrc.1997.6513","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1211_CR207","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000079414","volume":"11","author":"BL Spangelo","year":"2004","unstructured":"Spangelo BL, Horrell S, Goodwin AL, Shroff S, Jarvis WD (2004) Somatostatin and gamma-aminobutyric acid inhibit interleukin-1 beta-stimulated release of interleukin-6 from rat C6 glioma cells. NeuroImmunoModulation 11(5):332\u2013340. https:\/\/doi.org\/10.1159\/000079414","journal-title":"NeuroImmunoModulation"},{"issue":"1","key":"1211_CR208","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1677\/ERC-06-0026","volume":"14","author":"MC Zatelli","year":"2007","unstructured":"Zatelli MC, Piccin D, Vignali C, Tagliati F, Ambrosio MR, Bondanelli M et al (2007) Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion. Endocr Relat Cancer 14(1):91\u2013102. https:\/\/doi.org\/10.1677\/ERC-06-0026","journal-title":"Endocr Relat Cancer"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01211-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-022-01211-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01211-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T21:05:51Z","timestamp":1654635951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-022-01211-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":208,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1211"],"URL":"https:\/\/doi.org\/10.1007\/s11102-022-01211-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741695575.793592233","asserted-by":"object"}]},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"15 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No experimental activity has been performed either in humans or animals. We have only performed a review of the current literature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal rights"}}]}}